Home/Filings/4/0001104659-24-025035
4//SEC Filing

HAASER CHARLES B 4

Accession 0001104659-24-025035

CIK 0001121702other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:29 PM ET

Size

5.9 KB

Accession

0001104659-24-025035

Insider Transaction Report

Form 4
Period: 2024-02-15
HAASER CHARLES B
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2024-02-15$0.30/sh+100,000$30,000110,302 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    30,559
Footnotes (2)
  • [F1]The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/15/2024 and the remaining 50% on 2/15/2025.
  • [F2]Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.

Issuer

YIELD10 BIOSCIENCE, INC.

CIK 0001121702

Entity typeother

Related Parties

1
  • filerCIK 0001230903

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:29 PM ET
Size
5.9 KB